Following the adverse outcome pathway from micronucleus to cancer using H2B-eGFP transgenic healthy stem cells.
Hölzel BN, Pfannkuche K, Allner B, Allner HT, Hescheler J, Derichsweiler D, Hollert H, Schiwy A, Brendt J, Schaffeld M, Froschauer A, Stahlschmidt-Allner P.
Hölzel BN, et al. Among authors: hollert h.
Arch Toxicol. 2020 Sep;94(9):3265-3280. doi: 10.1007/s00204-020-02821-3. Epub 2020 Jul 22.
Arch Toxicol. 2020.
PMID: 32700163
Free PMC article.